The ratings agency also affirmed the long-term and underlying ratings on the hospital authority’s revenue bonds and the “AAA/A-1+” dual rating on its variable-rate demand bonds.
“KUHA’s market presence is exceptionally strong, characterized by its dominant market share in a large primary service area, strong and growing patient volume activity given its unique high-end specialty service offerings and its position as the region’s academic medical center,” S&P analyst Kevin Holloran said.
The outlook is stable, reflecting S&P Global Ratings’ view the hospital authority will maintain its “strong credit fundamentals, good enterprise profile and solid business position,” for the two-year outlook period, said Mr. Holloran.
More articles on healthcare finance:
Fitch places Meridian Health System’s bonds on rating watch positive
Fitch upgrades rating on Children’s Hospital Medical Center of Akron to ‘AA-‘
S&P downgrades rating on Covenant Health’s bonds to ‘BBB+’
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
